Product Information
PAROXETINE HCL 40 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0983 per EA under NDC 00378700410. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 13, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378700410
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078902FDA Approved
3/13/2008
TE Code
AB
On Market Since
3/24/2008
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 40 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 28.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0983 per EA |
|---|---|
| All-time high | $0.1511 (Feb 12, 2014) |
| All-time low | $0.0864 (Nov 20, 2024) |
| 52-week high | $0.1131 |
| 52-week low | $0.0983 |
| Median price | $0.1229 |
| Average price | $0.1234 |
| Largest weekly change | +30.0% (Aug 21, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 40 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0983 per EA (NDC 00378700410), effective Aug 19, 2026.
How has the price of PAROXETINE HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 40 MG TABLET has declined 28.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 40 MG TABLET?
Since Nov 28, 2013, the NADAC for PAROXETINE HCL 40 MG TABLET has ranged from a low of $0.0864 (Nov 20, 2024) to a high of $0.1511 (Feb 12, 2014), with a median of $0.1229 per EA.
Are there cheaper alternatives to PAROXETINE HCL 40 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PAROXETINE HCL 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PAROXETINE HCL 40 MG TABLET?
PAROXETINE HCL 40 MG TABLET (NDC 00378700410) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.